TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

Mark A Dickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.